Disclosure of interest: All authors : nothing to disclose Poster Session II - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P1000 - ESOC25-739 WATCHMAN: 5-YEAR REAL-WORLD LONG-TERM OUTCOMES IN AF PATIENTS WITH LEFT APPENDAGE CLOSURE Jiangyong Min 1 , Beenish Javaid 1 , Richard Nguyen 2 , Asad Ahrar 1 , Nadeem Khan 1 , Malgorzata Miller 1 , Nabil Wees 1 , Elizabeth Evans 1 , Maulik Kantawala 1 , Tarah Moelker 1 , Musa Dahu 1 , William Merhi 1 , Duane Berkompas 1 1 Corewell Health West, Michigan State University, Grand Rapids, United States, 2 Michigan State University College of Human Medicine, Michigan State University, Grand Rapids, United States Background and Aims: Left appendage occlusion (LAAO) with Watchman has been proven to be an effective alternative to warfarin
These compounds don't just target muscles they affect the entire body in ways scientists are only beginning to understand
The safety information below is the documented drug-label class information, reproduced as reference
Most interestingly, although both GRK and PKC contribute to platelet-activating factor-mediated desensitization, only PKC mediates WEB2086 desensitization, yet it is different PKC isoforms that mediate the platelet-activating factor versus WEB2086 desensitization (Dupre et al ., 2007)
The harmonic restraints were released in five steps, transitioning the system from an NVT to an NPT ensemble over 100 ps
Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor 1 in mice
